farnesol has been researched along with Antiphospholipid Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blank, M; Chapman, J; Katzav, A; Kloog, Y; Korczyn, AD; Molina, V; Shoenfeld, Y | 1 |
| Aronovich, R; Chapman, J; Gurwitz, D; Kloog, Y | 1 |
| Blank, M; Chapman, J; Karussis, DM; Katzav, A; Kloog, Y; Korczyn, AD; Niv, H; Rabinowitz, R; Shoenfeld, Y; Wang, N | 1 |
3 other study(ies) available for farnesol and Antiphospholipid Syndrome
| Article | Year |
|---|---|
Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome.
Topics: Animals; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Autoantibodies; beta 2-Glycoprotein I; Disease Models, Animal; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Farnesol; Female; Freund's Adjuvant; Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred MRL lpr; ras Proteins; Salicylates; Time Factors | 2003 |
Antiphospholipid antibodies, thrombin and LPS activate brain endothelial cells and Ras-dependent pathways through distinct mechanisms.
Topics: Animals; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Brain; Cell Line; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Farnesol; Female; Humans; Immunoglobulin G; Intercellular Adhesion Molecule-1; Lipopolysaccharides; Male; Phosphorylation; ras Proteins; Rats; Salicylates; Thrombin | 2005 |
Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS).
Topics: Animals; Antiphospholipid Syndrome; Autoantibodies; Autoimmune Diseases; Farnesol; Female; In Vitro Techniques; Lupus Erythematosus, Systemic; Lymphatic Diseases; Lymphocyte Activation; Lymphocytes; Mice; Mice, Inbred MRL lpr; ras Proteins; Salicylates | 2001 |